首页 > 最新文献

JAMA surgery最新文献

英文 中文
Precision in Emergency Surgery. 急诊外科的精确性。
IF 14.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-21 DOI: 10.1001/jamasurg.2025.6164
Evelyn I Truong, Graciela Bauza, Brian S Zuckerbraun
{"title":"Precision in Emergency Surgery.","authors":"Evelyn I Truong, Graciela Bauza, Brian S Zuckerbraun","doi":"10.1001/jamasurg.2025.6164","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.6164","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":" ","pages":""},"PeriodicalIF":14.9,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146010143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Esophagectomy vs Active Surveillance in Clinical Complete Responders After Neoadjuvant Chemoradiation. 食管切除术与主动监测对新辅助放化疗后临床完全缓解者的影响。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-21 DOI: 10.1001/jamasurg.2025.5890
Adom Bondzi-Simpson,Vaibhav Gupta,Tiago Ribeiro,Michael Ko,Steven H Lin,Natalie G Coburn,Julie Hallet,Biniam Kidane
ImportanceThe Surgery as Needed for Oesophageal Cancer (SANO) trial introduced active surveillance as a noninferior alternative to esophagectomy for patients with esophageal cancer who achieve a clinical complete response (cCR) after neoadjuvant chemoradiation (nCRT). However, concerns remain about recurrence risk, long-term survival, and quality-of-life trade-offs with organ-preserving strategies.ObjectiveTo evaluate the long-term comparative effectiveness of active surveillance vs standard esophagectomy in patients with cCR following nCRT for locally advanced esophageal cancer, using updated data from the SANO trial.Design, Setting, and ParticipantsThis decision analytical model used Markov modeling and probabilities and utility inputs derived from the SANO trial and existing literature. The base case was a 60-year-old male with good functional status and cT3N1M0 esophageal cancer achieving cCR after nCRT.ExposuresStandard routine esophagectomy vs active surveillance after neoadjuvant chemoradiation.Main Outcomes and MeasuresThe primary outcome was quality-adjusted life-years (QALYs); the secondary outcome was life-years. Additional model scenarios explored (1) quality-of-life impacts of esophagectomy modeled as a time-varying covariate and (2) 2-year outcomes to align with the SANO trial time horizon. Sensitivity analyses evaluated recurrence probabilities and surgery-related quality-of-life trade-offs.ResultsAt 5 years, standard surgery yielded greater QALYs (1.74 vs 1.34; incremental gain of 0.40 QALYs or ~4.8 months in perfect health) and life-years (3.11 vs 2.41; incremental gain of 0.70 life-years or ~8.4 months) compared with active surveillance. However, at a 2-year horizon, active surveillance was preferred for QALYs (incremental gain of ~15 days), consistent with the SANO trial. Sensitivity analyses revealed the model favored active surveillance when the recurrence probability was less than 43%, the likelihood of local/resectable recurrence was greater than 94%, or the negative quality-of-life impact of esophagectomy was substantial. Modeling esophagectomy's quality-of-life impact as time limited further strengthened surgery's long-term QALY benefit.Conclusions and RelevanceThis study found that while active surveillance offers short-term quality-of-life benefits and may be appropriate in select patients, particularly those at low recurrence risk or with high surgical risk, esophagectomy remains the preferred strategy for maximizing long-term survival and QALYs. These findings support a nuanced, individualized approach to post-nCRT management, balancing organ preservation with long-term oncologic outcomes.
食管癌按需手术(SANO)试验将主动监测作为食管癌患者在新辅助放化疗(nCRT)后达到临床完全缓解(cCR)的非次优选择。然而,对器官保存策略的复发风险、长期生存和生活质量权衡的担忧仍然存在。目的利用SANO试验的最新数据,评估主动监测与标准食管切除术对局部晚期食管癌nCRT后cCR患者的长期比较效果。设计、设置和参与者这个决策分析模型使用了马尔可夫模型以及从SANO试验和现有文献中获得的概率和效用输入。基本病例为60岁男性,功能状态良好,cT3N1M0食管癌在nCRT后达到cCR。标准常规食管切除术与新辅助放化疗后的主动监测。主要结局和测量:主要结局为质量调整生命年(QALYs);次要结果是生命年。其他模型场景探讨了(1)食管切除术作为时变协变量建模的生活质量影响和(2)与SANO试验时间范围一致的2年结果。敏感性分析评估了复发概率和手术相关的生活质量权衡。结果5年后,与主动监测相比,标准手术获得更高的QALYs (1.74 vs 1.34;完全健康时增加0.40 QALYs或约4.8个月)和生命年(3.11 vs 2.41;增加0.70生命年或约8.4个月)。然而,与SANO试验一致,在2年的期限内,主动监测是QALYs(增量增益约15天)的首选。敏感性分析显示,当复发概率小于43%,局部/可切除复发的可能性大于94%,或食管切除术对生活质量的负面影响很大时,该模型更倾向于主动监测。模拟食管切除术在时间限制下对生活质量的影响,进一步加强了手术的长期质量效益。结论和相关性本研究发现,虽然主动监测可以提供短期的生活质量益处,并且可能适用于特定的患者,特别是那些复发风险低或手术风险高的患者,但食管切除术仍然是最大化长期生存率和QALYs的首选策略。这些发现支持一种微妙的、个性化的ncrt后管理方法,平衡器官保存与长期肿瘤预后。
{"title":"Esophagectomy vs Active Surveillance in Clinical Complete Responders After Neoadjuvant Chemoradiation.","authors":"Adom Bondzi-Simpson,Vaibhav Gupta,Tiago Ribeiro,Michael Ko,Steven H Lin,Natalie G Coburn,Julie Hallet,Biniam Kidane","doi":"10.1001/jamasurg.2025.5890","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.5890","url":null,"abstract":"ImportanceThe Surgery as Needed for Oesophageal Cancer (SANO) trial introduced active surveillance as a noninferior alternative to esophagectomy for patients with esophageal cancer who achieve a clinical complete response (cCR) after neoadjuvant chemoradiation (nCRT). However, concerns remain about recurrence risk, long-term survival, and quality-of-life trade-offs with organ-preserving strategies.ObjectiveTo evaluate the long-term comparative effectiveness of active surveillance vs standard esophagectomy in patients with cCR following nCRT for locally advanced esophageal cancer, using updated data from the SANO trial.Design, Setting, and ParticipantsThis decision analytical model used Markov modeling and probabilities and utility inputs derived from the SANO trial and existing literature. The base case was a 60-year-old male with good functional status and cT3N1M0 esophageal cancer achieving cCR after nCRT.ExposuresStandard routine esophagectomy vs active surveillance after neoadjuvant chemoradiation.Main Outcomes and MeasuresThe primary outcome was quality-adjusted life-years (QALYs); the secondary outcome was life-years. Additional model scenarios explored (1) quality-of-life impacts of esophagectomy modeled as a time-varying covariate and (2) 2-year outcomes to align with the SANO trial time horizon. Sensitivity analyses evaluated recurrence probabilities and surgery-related quality-of-life trade-offs.ResultsAt 5 years, standard surgery yielded greater QALYs (1.74 vs 1.34; incremental gain of 0.40 QALYs or ~4.8 months in perfect health) and life-years (3.11 vs 2.41; incremental gain of 0.70 life-years or ~8.4 months) compared with active surveillance. However, at a 2-year horizon, active surveillance was preferred for QALYs (incremental gain of ~15 days), consistent with the SANO trial. Sensitivity analyses revealed the model favored active surveillance when the recurrence probability was less than 43%, the likelihood of local/resectable recurrence was greater than 94%, or the negative quality-of-life impact of esophagectomy was substantial. Modeling esophagectomy's quality-of-life impact as time limited further strengthened surgery's long-term QALY benefit.Conclusions and RelevanceThis study found that while active surveillance offers short-term quality-of-life benefits and may be appropriate in select patients, particularly those at low recurrence risk or with high surgical risk, esophagectomy remains the preferred strategy for maximizing long-term survival and QALYs. These findings support a nuanced, individualized approach to post-nCRT management, balancing organ preservation with long-term oncologic outcomes.","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"11 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146005275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Public Views on State Licensure of Internationally Trained Surgeons Without US Residency. 公众对无美国居留权的国际培训外科医生国家执照的看法。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-21 DOI: 10.1001/jamasurg.2025.6145
Forrest Bohler,Aaquib Noorani,Jesse C Selber,Karam Hadid,Angelis Lau,George A Flores,Sergey G Toshinskiy,Kongkrit Chaiyasate
ImportanceAs part of an effort to boost physician supply and opportunity, several US states have recently enacted laws permitting internationally trained physicians to practice without completing an Accreditation Council for Graduate Medical Education-accredited residency or fellowship, representing a major departure from long-standing licensure norms. Little is known about how the public perceives these laws, particularly in surgical fields in which technical competency and patient trust are paramount.ObjectiveTo assess public perceptions of state laws permitting internationally trained surgeons to practice in the US without US-based residency training.Design, Setting, and ParticipantsThis cross-sectional study involving perspectives of US adults on state licensure of internationally trained surgeons to address surgical workforce shortages was conducted in July 2025 using an online crowdsourcing platform (Amazon Mechanical Turk; Amazon Mechanical Turk, Inc). A 21-item survey was administered through Qualtrics (Qualtrics, LLC). Quality control included definitional understanding, attention checks, and time-based screening.Main Outcomes and MeasuresPrimary outcomes included support for licensure laws for internationally trained surgeons, ethical concerns regarding international brain drain, perceived training equivalence, personal comfort with internationally trained surgeon care, hospital trust, and preferences for regulatory oversight. Subgroup analyses were performed by sex and self-defined political views using χ2 testing.ResultsOf 1270 initial responses, 1066 (83.9%) passed quality criteria and were analyzed. Among 1066 respondents (634 male [59.5%], median [IQR] age 33 [29-35] years), 906 (85.0%) supported state licensure laws for internationally trained surgeons. Most respondents (991; 93.0%) believed such laws would improve access and 856 (80.3%) felt diversity would improve, yet 755 (70.8%) expressed ethical concerns about international brain drain. Regarding training, a majority of respondents (787; 73.8%) did not view international training as equivalent to US training, and 831 (78.0%) reported they would be less likely to select an internationally trained surgeon for surgery. Regarding informed consent, nearly all respondents (1005; 94.3%) supported mandatory disclosure of training background. Males (575 of 634 [90.7%], P < .001) and conservatives (512 of 569 [89.9%], P < .001) were significantly more supportive of the laws, whereas liberals were more likely to express ethical concern (248 of 301 [82.4%], P < .001) and discomfort with internationally trained surgeon care (257 of 301 [85.3%], P = .02). The majority of respondents (817 [76.6%]) supported restricting internationally trained surgeon practice to underserved areas.Conclusions and RelevanceFindings of this study suggest that the US public generally supports licensure laws for internationally trained surgeons but with important caveats, including geographic restriction of prac
作为努力增加医生供应和机会的一部分,美国几个州最近颁布了法律,允许受过国际培训的医生在没有完成研究生医学教育认证委员会认可的住院医师或奖学金的情况下执业,这与长期存在的执照规范有很大的不同。对于公众如何看待这些法律,尤其是在技术能力和患者信任至关重要的外科领域,人们知之甚少。目的评估公众对允许接受国际培训的外科医生在美国执业而不接受美国住院医师培训的州法律的看法。设计、环境和参与者这项横断面研究涉及美国成年人对国际培训外科医生的国家执照的看法,以解决外科劳动力短缺问题,该研究于2025年7月通过在线众包平台(Amazon Mechanical Turk; Amazon Mechanical Turk, Inc .)进行。通过Qualtrics (Qualtrics, LLC)进行了21项调查。质量控制包括理解定义、注意检查和基于时间的筛选。主要结果和措施主要结果包括对国际培训外科医生执照法的支持、对国际人才流失的伦理关注、对培训等效性的感知、个人对国际培训外科医生护理的满意度、医院信任以及对监管监督的偏好。采用χ2检验对性别和自我定义的政治观点进行亚组分析。结果1270份初步回复中,1066份(83.9%)符合质量标准。在1066名受访者中(634名男性,占59.5%,中位[IQR]年龄33[29-35]岁),906名(85.0%)受访者支持国家对接受国际培训的外科医生颁发执照的法律。大多数受访者(991人,93.0%)认为这些法律将改善准入,856人(80.3%)认为多样性将得到改善,但755人(70.8%)表达了对国际人才流失的道德担忧。在培训方面,大多数受访者(787人,73.8%)不认为国际培训等同于美国培训,831人(78.0%)表示他们不太可能选择受过国际培训的外科医生进行手术。在知情同意方面,几乎所有受访者(1005人,94.3%)都支持强制披露培训背景。634人中男性575人(90.7%),P <。001)和保守(569例中的512例[89.9%],P < 0.001)。001)明显更支持法律,而自由主义者更有可能表达道德担忧(301人中有248人[82.4%],P <。301人中有257人(85.3%)感到不适(P = .02)。大多数受访者(817人[76.6%])支持将国际培训的外科医生执业限制在服务不足的地区。本研究的结论和相关性发现表明,美国公众普遍支持国际培训外科医生的执照法律,但有重要的警告,包括执业的地理限制,对披露培训背景的强烈偏好,对人才流失的道德担忧,以及不愿亲自接受国际培训外科医生的护理。决策者需要在劳动力扩张与保障患者安全、透明度和全球公平之间取得平衡。随着国际训练的外科医生开始进入美国外科实践,这些发现为未来的研究提供了重要的基线。
{"title":"Public Views on State Licensure of Internationally Trained Surgeons Without US Residency.","authors":"Forrest Bohler,Aaquib Noorani,Jesse C Selber,Karam Hadid,Angelis Lau,George A Flores,Sergey G Toshinskiy,Kongkrit Chaiyasate","doi":"10.1001/jamasurg.2025.6145","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.6145","url":null,"abstract":"ImportanceAs part of an effort to boost physician supply and opportunity, several US states have recently enacted laws permitting internationally trained physicians to practice without completing an Accreditation Council for Graduate Medical Education-accredited residency or fellowship, representing a major departure from long-standing licensure norms. Little is known about how the public perceives these laws, particularly in surgical fields in which technical competency and patient trust are paramount.ObjectiveTo assess public perceptions of state laws permitting internationally trained surgeons to practice in the US without US-based residency training.Design, Setting, and ParticipantsThis cross-sectional study involving perspectives of US adults on state licensure of internationally trained surgeons to address surgical workforce shortages was conducted in July 2025 using an online crowdsourcing platform (Amazon Mechanical Turk; Amazon Mechanical Turk, Inc). A 21-item survey was administered through Qualtrics (Qualtrics, LLC). Quality control included definitional understanding, attention checks, and time-based screening.Main Outcomes and MeasuresPrimary outcomes included support for licensure laws for internationally trained surgeons, ethical concerns regarding international brain drain, perceived training equivalence, personal comfort with internationally trained surgeon care, hospital trust, and preferences for regulatory oversight. Subgroup analyses were performed by sex and self-defined political views using χ2 testing.ResultsOf 1270 initial responses, 1066 (83.9%) passed quality criteria and were analyzed. Among 1066 respondents (634 male [59.5%], median [IQR] age 33 [29-35] years), 906 (85.0%) supported state licensure laws for internationally trained surgeons. Most respondents (991; 93.0%) believed such laws would improve access and 856 (80.3%) felt diversity would improve, yet 755 (70.8%) expressed ethical concerns about international brain drain. Regarding training, a majority of respondents (787; 73.8%) did not view international training as equivalent to US training, and 831 (78.0%) reported they would be less likely to select an internationally trained surgeon for surgery. Regarding informed consent, nearly all respondents (1005; 94.3%) supported mandatory disclosure of training background. Males (575 of 634 [90.7%], P &lt; .001) and conservatives (512 of 569 [89.9%], P &lt; .001) were significantly more supportive of the laws, whereas liberals were more likely to express ethical concern (248 of 301 [82.4%], P &lt; .001) and discomfort with internationally trained surgeon care (257 of 301 [85.3%], P = .02). The majority of respondents (817 [76.6%]) supported restricting internationally trained surgeon practice to underserved areas.Conclusions and RelevanceFindings of this study suggest that the US public generally supports licensure laws for internationally trained surgeons but with important caveats, including geographic restriction of prac","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"87 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146005276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Error in Table. 表中出现错误。
IF 14.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-21 DOI: 10.1001/jamasurg.2025.6468
{"title":"Error in Table.","authors":"","doi":"10.1001/jamasurg.2025.6468","DOIUrl":"10.1001/jamasurg.2025.6468","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":" ","pages":""},"PeriodicalIF":14.9,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12824842/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146010148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Window on the Public's Perception of Internationally Trained Surgeons. 公众对接受国际培训的外科医生认知的窗口。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-21 DOI: 10.1001/jamasurg.2025.6152
Kamal M F Itani,Marco G Patti
{"title":"A Window on the Public's Perception of Internationally Trained Surgeons.","authors":"Kamal M F Itani,Marco G Patti","doi":"10.1001/jamasurg.2025.6152","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.6152","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"16 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146005279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rizedisben Must Address Tumor-Nerve Co-Imaging for Clinical Translation. Rizedisben必须解决肿瘤-神经联合成像的临床翻译问题。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-14 DOI: 10.1001/jamasurg.2025.6026
Lingling Meng,Yupeng Di
{"title":"Rizedisben Must Address Tumor-Nerve Co-Imaging for Clinical Translation.","authors":"Lingling Meng,Yupeng Di","doi":"10.1001/jamasurg.2025.6026","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.6026","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"3 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145961491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preempting the Trough of Disillusionment in Surgical AI. 外科人工智能的幻灭低谷。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-14 DOI: 10.1001/jamasurg.2025.6035
Jayson S Marwaha,Daniel A Hashimoto
{"title":"Preempting the Trough of Disillusionment in Surgical AI.","authors":"Jayson S Marwaha,Daniel A Hashimoto","doi":"10.1001/jamasurg.2025.6035","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.6035","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"20 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145961492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expectations vs Reality of an Intraoperative Artificial Intelligence Intervention. 术中人工智能干预的期望与现实。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-14 DOI: 10.1001/jamasurg.2025.6029
Melissa Thornton,Benjamin A Y Cher,Cameron Macdonald,Jocelyn G Baker,Elisa L Marten,Don Mai,Ganesh Sankaranarayanan,Courtney J Balentine
ImportanceHaving significant gaps between the expectations and reality of artificial intelligence-based programs can be a major barrier to successful implementation. This is the first multisite implementation assessment of gaps between surgeon expectations and real-world effects of the Operating Room Black Box, a novel intervention that leverages artificial intelligence to improve surgical outcomes.ObjectiveTo identify barriers and facilitators to implementing artificial intelligence-based interventions that improve intra- and postoperative care.Design, Setting, and ParticipantsThis qualitative study was conducted at 3 large academic centers via semistructured interviews with surgeons and implementation leaders of the AI intervention to identify areas where expectations of the technology misaligned with their experiences. Thirty surgeons and 17 implementation leaders from 3 centers that implemented the AI intervention were interviewed. Data were collected and analyzed between 2021 and 2024.ExposureImplementation of the AI intervention.Main Outcomes and MeasuresThe primary outcome was areas of misalignment between participant expectations of the AI intervention technology and actual program deliverables.ResultsOf 30 surgeons and 17 implementation leaders interviewed, most surgeons (17 [57%]) were between the ages of 35 and 50 years, and implementation leaders were older, typically between 51 and 80 years old (6 [35%]). Eight surgeons (27%) and 4 implementation leaders (24%) were female. Most surgeons (17 [57%]) had neutral views of the technology, 11 (37%) expressed positive views, and 2 (7%) had negative views. Interviewees identified the following 4 major themes that highlighted misalignment between user expectations and the experience of using the technology: (1) the artificial intelligence model needed considerable additional training to be usable; (2) accessing data on surgical cases was difficult and time consuming; (3) the program showed limited ability to predict postoperative complications; and (4) the program generated few academic deliverables.Conclusions and RelevancePer the results of this multisite qualitative study, successfully implementing interventions based on artificial intelligence may require deliberate efforts to minimize gaps between what surgeons expect from the interventions and what they can deliver. Our evaluation of this study's AI intervention offers lessons for addressing this critical barrier to implementation.
在基于人工智能的项目的期望和现实之间存在重大差距可能是成功实施的主要障碍。这是第一次对外科医生期望与手术室黑匣子实际效果之间差距的多地点实施评估,手术室黑匣子是一种利用人工智能改善手术结果的新型干预措施。目的确定实施基于人工智能的干预措施以改善手术内和术后护理的障碍和促进因素。设计、环境和参与者本定性研究在3个大型学术中心进行,通过对外科医生和人工智能干预实施负责人进行半结构化访谈,以确定对技术的期望与他们的经验不一致的领域。访谈了来自3个实施人工智能干预的中心的30名外科医生和17名实施负责人。在2021年至2024年期间收集并分析了数据。曝光人工智能干预的实施。主要结果和措施主要结果是参与者对人工智能干预技术的期望与实际项目可交付成果之间的不一致领域。结果访谈的30名外科医生和17名实施领导中,年龄在35 ~ 50岁之间的外科医生最多(17名[57%]),实施领导年龄较大(6名[35%]),年龄在51 ~ 80岁之间。8名外科医生(27%)和4名执行负责人(24%)为女性。大多数外科医生(17位[57%])对该技术持中立态度,11位(37%)持积极态度,2位(7%)持消极态度。受访者确定了以下4个主要主题,突出了用户期望与使用该技术的体验之间的不一致:(1)人工智能模型需要大量额外的培训才能使用;(2)获取手术病例数据困难且耗时;(3)该程序预测术后并发症的能力有限;(4)该项目产生的学术成果很少。结论和相关性根据这项多地点定性研究的结果,成功实施基于人工智能的干预可能需要精心的努力,以最大限度地减少外科医生对干预的期望与他们所能提供的之间的差距。我们对这项研究的人工智能干预的评估为解决这一实施的关键障碍提供了经验教训。
{"title":"Expectations vs Reality of an Intraoperative Artificial Intelligence Intervention.","authors":"Melissa Thornton,Benjamin A Y Cher,Cameron Macdonald,Jocelyn G Baker,Elisa L Marten,Don Mai,Ganesh Sankaranarayanan,Courtney J Balentine","doi":"10.1001/jamasurg.2025.6029","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.6029","url":null,"abstract":"ImportanceHaving significant gaps between the expectations and reality of artificial intelligence-based programs can be a major barrier to successful implementation. This is the first multisite implementation assessment of gaps between surgeon expectations and real-world effects of the Operating Room Black Box, a novel intervention that leverages artificial intelligence to improve surgical outcomes.ObjectiveTo identify barriers and facilitators to implementing artificial intelligence-based interventions that improve intra- and postoperative care.Design, Setting, and ParticipantsThis qualitative study was conducted at 3 large academic centers via semistructured interviews with surgeons and implementation leaders of the AI intervention to identify areas where expectations of the technology misaligned with their experiences. Thirty surgeons and 17 implementation leaders from 3 centers that implemented the AI intervention were interviewed. Data were collected and analyzed between 2021 and 2024.ExposureImplementation of the AI intervention.Main Outcomes and MeasuresThe primary outcome was areas of misalignment between participant expectations of the AI intervention technology and actual program deliverables.ResultsOf 30 surgeons and 17 implementation leaders interviewed, most surgeons (17 [57%]) were between the ages of 35 and 50 years, and implementation leaders were older, typically between 51 and 80 years old (6 [35%]). Eight surgeons (27%) and 4 implementation leaders (24%) were female. Most surgeons (17 [57%]) had neutral views of the technology, 11 (37%) expressed positive views, and 2 (7%) had negative views. Interviewees identified the following 4 major themes that highlighted misalignment between user expectations and the experience of using the technology: (1) the artificial intelligence model needed considerable additional training to be usable; (2) accessing data on surgical cases was difficult and time consuming; (3) the program showed limited ability to predict postoperative complications; and (4) the program generated few academic deliverables.Conclusions and RelevancePer the results of this multisite qualitative study, successfully implementing interventions based on artificial intelligence may require deliberate efforts to minimize gaps between what surgeons expect from the interventions and what they can deliver. Our evaluation of this study's AI intervention offers lessons for addressing this critical barrier to implementation.","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"30 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145961490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implications of Eliminating Medicare's Inpatient Only List. 取消医疗保险住院病人名单的影响。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-14 DOI: 10.1001/jamasurg.2025.6067
Julia H Song,Patricia L Turner,Thomas C Tsai
{"title":"Implications of Eliminating Medicare's Inpatient Only List.","authors":"Julia H Song,Patricia L Turner,Thomas C Tsai","doi":"10.1001/jamasurg.2025.6067","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.6067","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"177 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145961493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk-Reducing Bilateral Mastectomy and Mortality in Carriers of BRCA1 and BRCA2 Variants: A Systematic Review and Meta-Analysis. 降低BRCA1和BRCA2变异携带者双侧乳房切除术风险和死亡率:一项系统综述和荟萃分析。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-07 DOI: 10.1001/jamasurg.2025.5929
Cathal O'Reilly,Jennifer L McGarry,Alexandra M Zaborowski,Matthew G Davey,Denis Evoy,Jane Rothwell,Damian McCartan,Claire L Rutherford,Michael R Boland,Ruth S Prichard
ImportanceRisk-reducing bilateral mastectomy reduces the incidence of breast cancer in female carriers of the BRCA pathogenic variants, but its association with mortality remains uncertain.ObjectiveTo evaluate the association between risk-reducing bilateral mastectomy and overall and breast cancer-specific mortality in female carriers of BRCA pathogenic variants.Data SourcesPubMed, Scopus, CINAHL, Embase, and CENTRAL were searched in May 2025, with English-language restriction and no date limit. Reference lists of included studies and relevant reviews were also examined.Study SelectionEligible studies compared female carriers of BRCA1 and BRCA2 pathogenic variants who underwent risk-reducing bilateral mastectomy with those who did not and reported overall mortality or breast cancer-specific mortality. Studies including patients with a history of breast cancer were excluded.Data Extraction and SynthesisThis meta-analysis followed the Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines. Two authors independently performed study selection, data extraction, and risk of bias assessment (using Risk of Bias in Nonrandomized Studies-of Interventions, version 2). Odds ratios (ORs) and hazard ratios (HRs) were pooled using fixed- and random-effects models according to methodological assessment.Main Outcomes and MeasuresOverall and breast cancer-specific mortality.ResultsSix observational studies met the inclusion criteria, comprising 6135 carriers of the BRCA1 or BRCA2 variant. Weighted median age at inclusion was 38.0 years, with reported age ranges spanning 15.3 to 85.3 years. Risk-reducing bilateral mastectomy was associated with lower overall mortality in both unadjusted (OR, 0.38; 95% CI, 0.27-0.55; P < .001) and adjusted (HR, 0.37; 95% CI, 0.23-0.60; P < .001) analyses. Breast cancer-specific mortality was also reduced (OR, 0.19; 95% CI, 0.08-0.47; P < .001; HR, 0.14; 95% CI, 0.04-0.49; P = .002).Conclusions and RelevanceRisk-reducing bilateral mastectomy was associated with lower overall and breast cancer-specific mortality in carriers of the BRCA variants. These findings support the role of risk-reducing bilateral mastectomy as a potentially life-extending intervention and may inform the shared decision-making discussions in these women.
降低风险的双侧乳房切除术降低了BRCA致病变异女性携带者的乳腺癌发病率,但其与死亡率的关系仍不确定。目的评估降低风险的双侧乳房切除术与BRCA致病变异女性携带者的总体死亡率和乳腺癌特异性死亡率之间的关系。数据源pubmed, Scopus, CINAHL, Embase和CENTRAL于2025年5月检索,有英文限制,无日期限制。还审查了纳入研究的参考清单和相关综述。研究选择:符合条件的研究比较了BRCA1和BRCA2致病变异的女性携带者,她们接受了降低风险的双侧乳房切除术,并报告了总死亡率或乳腺癌特异性死亡率。有乳腺癌病史的患者被排除在外。本荟萃分析遵循流行病学观察性研究荟萃分析(MOOSE)指南。两位作者独立进行了研究选择、数据提取和偏倚风险评估(使用《非随机研究干预的偏倚风险》,版本2)。根据方法学评估,采用固定效应和随机效应模型汇总优势比(ORs)和风险比(hr)。主要结局和测量:总体死亡率和乳腺癌特异性死亡率。结果6项观察性研究符合纳入标准,包括6135名BRCA1或BRCA2变异携带者。纳入时的加权中位年龄为38.0岁,报告的年龄范围为15.3至85.3岁。降低风险的双侧乳房切除术与两组患者较低的总死亡率相关(OR, 0.38; 95% CI, 0.27-0.55; P <。0.001)和调整后(HR, 0.37; 95% CI, 0.23-0.60; P <。001)分析。乳腺癌特异性死亡率也降低(OR, 0.19; 95% CI, 0.08-0.47; P < .001; HR, 0.14; 95% CI, 0.04-0.49; P = .002)。结论和相关性:降低风险的双侧乳房切除术与BRCA变异携带者较低的总体死亡率和乳腺癌特异性死亡率相关。这些发现支持降低风险的双侧乳房切除术作为一种潜在的延长生命的干预措施的作用,并可能为这些妇女的共同决策讨论提供信息。
{"title":"Risk-Reducing Bilateral Mastectomy and Mortality in Carriers of BRCA1 and BRCA2 Variants: A Systematic Review and Meta-Analysis.","authors":"Cathal O'Reilly,Jennifer L McGarry,Alexandra M Zaborowski,Matthew G Davey,Denis Evoy,Jane Rothwell,Damian McCartan,Claire L Rutherford,Michael R Boland,Ruth S Prichard","doi":"10.1001/jamasurg.2025.5929","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.5929","url":null,"abstract":"ImportanceRisk-reducing bilateral mastectomy reduces the incidence of breast cancer in female carriers of the BRCA pathogenic variants, but its association with mortality remains uncertain.ObjectiveTo evaluate the association between risk-reducing bilateral mastectomy and overall and breast cancer-specific mortality in female carriers of BRCA pathogenic variants.Data SourcesPubMed, Scopus, CINAHL, Embase, and CENTRAL were searched in May 2025, with English-language restriction and no date limit. Reference lists of included studies and relevant reviews were also examined.Study SelectionEligible studies compared female carriers of BRCA1 and BRCA2 pathogenic variants who underwent risk-reducing bilateral mastectomy with those who did not and reported overall mortality or breast cancer-specific mortality. Studies including patients with a history of breast cancer were excluded.Data Extraction and SynthesisThis meta-analysis followed the Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines. Two authors independently performed study selection, data extraction, and risk of bias assessment (using Risk of Bias in Nonrandomized Studies-of Interventions, version 2). Odds ratios (ORs) and hazard ratios (HRs) were pooled using fixed- and random-effects models according to methodological assessment.Main Outcomes and MeasuresOverall and breast cancer-specific mortality.ResultsSix observational studies met the inclusion criteria, comprising 6135 carriers of the BRCA1 or BRCA2 variant. Weighted median age at inclusion was 38.0 years, with reported age ranges spanning 15.3 to 85.3 years. Risk-reducing bilateral mastectomy was associated with lower overall mortality in both unadjusted (OR, 0.38; 95% CI, 0.27-0.55; P < .001) and adjusted (HR, 0.37; 95% CI, 0.23-0.60; P < .001) analyses. Breast cancer-specific mortality was also reduced (OR, 0.19; 95% CI, 0.08-0.47; P < .001; HR, 0.14; 95% CI, 0.04-0.49; P = .002).Conclusions and RelevanceRisk-reducing bilateral mastectomy was associated with lower overall and breast cancer-specific mortality in carriers of the BRCA variants. These findings support the role of risk-reducing bilateral mastectomy as a potentially life-extending intervention and may inform the shared decision-making discussions in these women.","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"391 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145907801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JAMA surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1